Biotech and Money had the opportunity to speak with Alastair Smith, the CEO...

John Rountree, Managing Partner of Novasecta, a specialist pharmaceutical m...

Straight from the Inv€$table CEO Pitch Breakfast hosted by K&L Gates on Tue...

Francesco de Rubertis, Co-Founder and Partner of Medicxi Ventures, talks to...

Graham Lumsden, CEO of Motif Bio, talks to Biotech and Money about the comm...

Carl Sterritt, CEO of Shield Therapeutics, talks to Biotech and Money about...

Ian Tomlinson, Chairman at Apollo Therapeutics, talks to Biotech and Money ...

Biotech and Money had the opportunity to speak to Andy Smith CIO of Mann Bi...

We recently spoke to Denise Scots-Knightof MereoBioPharmaabout acquiring an...

10-12 years ago everyone was talking about cell therapy and regenerative me...

Biotech and Money recently had the opportunity to speak to Manuel Llobet, C...

Biotech and Money recently had the opportunity to catch up with Eddy Little...